tweenvest

Cardiogeni PLC (OFEX: CGNI)

Health Care · Biotechnology · GB

£0.07

0.00% today · -22.2% 1Y

Public summary
A free snapshot of Cardiogeni PLC, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Cardiogeni PLC (OFEX: CGNI) operates in the Biotechnology industry within the Health Care sector. The company is valued at $8.84M.

Over the last twelve months the share price has lost 22.2%, trading between 0.07 and 0.09.

Tweenvest scores Cardiogeni PLC across four factors: quality 66/100, value 58/100. Its strongest factor is quality.

CGNI price history

Nov 21, 2025 · 0.09Weekly closes 0.07 – 0.09Nov 18, 2026 · 0.07

Key figures

Market cap
$8.84M
Revenue (TTM)
$10.07M
P/E
-25.18
EPS
—
Dividend yield
—
Beta (5Y)
—
52-week high
£0.09
52-week low
£0.07
Avg volume (3M)
—
Shares outstanding
96.15M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Active Biotech AB (publ)OM: ACTI$9.13MSkr3.50-0.28%
Biovica International AB (publ)OM: BIOVIC B$8.97MSkr0.31-4.94%
Poxel S.A.ENXTPA: POXEL$8.91M€0.15-1.96%
IN8bio, Inc.NasdaqCM: INAB$8.86M$0.82+0.49%
1nKemia IUCT Group, S.A.BME: IKM$8.80M€0.310.00%
Radiopharm Theranostics LimitedASX: RAD$8.79MAU$0.00-25.00%
Patrys LimitedASX: PAB$8.75MAU$0.02-2.17%
Intensity Therapeutics, Inc.NasdaqCM: INTS$8.72M$2.64-1.12%

Browse every Biotechnology company →